Study of the Efficacy, Biodistribution, and Safety Profile of Therapeutic Gutless Adenovirus Vectors as a Prelude to a Phase I Clinical Trial for Glioblastoma

Glioblastoma multiforme (GBM) is the most common and most aggressive primary brain tumor in humans. Systemic immunity against gene therapy vectors has been shown to hamper therapeutic efficacy; however, helper-dependent high-capacity adenovirus (HC-Ad) vectors elicit sustained transgene expression,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Muhammad, AKMG, Puntel, M, Candolfi, M, Salem, A, Yagiz, K, Farrokhi, C, Kroeger, KM, Xiong, W, Curtin, JF, Liu, C, Lawrence, K, Bondale, NS, Lerner, J, Baker, GJ, Foulad, D, Pechnick, RN, Palmer, D, Ng, P, Lowenstein, PR, Castro, MG
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2908190/
https://ncbi.nlm.nih.gov/pubmed/20164833
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2009.260
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller